Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Œsophage
»
Néoplasie
27. Juillet 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 1969
Articles 1 - 20 / 39361
Comparison of induction chemotherapy followed by concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by surgery and (chemo)radiotherapy in locoregionally advanced hypopharyngeal carcinoma: a prospective cohort study.
Clin Transl Oncol
Zhao DW, Li SR, Yang F, Guo XF, Sun XZ, Li L, Tan SC, Qin JY, Qu YJ, Wang ZQ, Ma L, Wang PG.
PMID: 42507334 [PubMed - as supplied by publisher]
Adaptive 3D-CRT with CCRT for head and neck cancer: resource limited single center experience in Bangladesh.
Radiol Phys Technol
Al-Amin, Das PK, Saha SK, Mannan A, Tania AB, Alim S, Poddar P, Hasnat A, Islam R.
PMID: 42507086 [PubMed - as supplied by publisher]
Colon interposition after esophagectomy: a 15-year single-center experience.
Langenbecks Arch Surg
Kemeter M, Thumfart L, Heger P, Hüttner FJ, Diener MK, Giulini L, Dubecz A.
PMID: 42507071 [PubMed - indexed for MEDLINE]
A Weighted Neural Network Model Based on Laboratory Tests for Identifying Lymph Node Metastases in Esophageal Squamous Cell Carcinomas.
Biosensors (Basel)
Ouyang Q, Gao Z, Yang J, Wang S, Li Z, Zhang Y, Chen T, Xu X, Han R, Chen H.
PMID: 42505453 [PubMed - indexed for MEDLINE]
Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.
Future Oncol
Zhang Y, Jin Y, Zhang R, Zhao J, Li B.
PMID: 42504461 [PubMed - as supplied by publisher]
Integrating habitat-based radiomics, 3D deep learning, and clinical variables for detection of early-stage esophageal squamous cell carcinoma on noncontrast chest CT: A multicenter study.
Eur J Radiol
Ye C, Song D, Xu J, Li S, Sun H, Liu J, Wen C, Cao G.
PMID: 42501614 [PubMed - as supplied by publisher]
Risk of cancer in periodontal disease: an umbrella review of meta-analyses.
Front Immunol
Yuan J, Wang S, Xia S, Lou S, Yang H, Wei J, Chen Y, Yu L, Du Y, Yu L, Sun L, Wang S.
PMID: 42500648 [PubMed - indexed for MEDLINE]
Comparison of the diagnostic value of white light endoscopic, narrow band imaging, and iodine staining individually and in combination for early esophageal cancer and precancerous lesions.
Front Oncol
Yin X, Meng M.
PMID: 42500285 [PubMed]
Performance of DeepSeek V3 and ChatGPT-4o in answering esophageal cancer-related questions.
Medicine (Baltimore)
Yang Q, Yi J, Gong A, Li Y, Feng Q, Fu A, Li J, Zhan Y.
PMID: 42499121 [PubMed - indexed for MEDLINE]
Essential Updates 2024-2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization.
Ann Gastroenterol Surg
Oya S, Yagi K, Baba Y.
PMID: 42495683 [PubMed - as supplied by publisher]
Systematic Review and Meta-Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma.
Ann Gastroenterol Surg
Sakai M, Kuriyama K, Nagai K, Shirabe K, Saeki H.
PMID: 42495669 [PubMed - as supplied by publisher]
Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.
Front Immunol
Ye Y, Zhang L, Yang Z, Huang Y, Chen M, Zhang S, Zeng T, Chen C, Zheng B.
PMID: 42495613 [PubMed - indexed for MEDLINE]
Circular RNAs in esophageal squamous cell carcinoma: What do we know so far?
iScience
Yang M, Ye J, Xiong J, Chen Y, Zhao Y, Wang Z, Xu S, Wang J.
PMID: 42495543 [PubMed]
Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study.
Front Oncol
Jingu K, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Harada H, Takahashi M, Kamei T, Matsushita H.
PMID: 42494587 [PubMed]
Does adding immunotherapy to neoadjuvant chemotherapy increase postoperative morbidity in gastroesophageal junction adenocarcinoma? A propensity score-matched study.
Front Immunol
Zhang H, Huang Q, Du J, Wan X.
PMID: 42490951 [PubMed - indexed for MEDLINE]
A Simplified Nomogram for Primary Population-Based Screening of Esophageal Cancer: An Internally Validated Shandong Cohort Study Addressing Data Imbalance.
Risk Manag Healthc Policy
Hou J, He X, Gao F, Ren T, Ren L, Wang X.
PMID: 42488795 [PubMed]
Targeting notch signaling pathway in esophageal cancer: from molecular insights to therapies.
Oncol Rev
Bhattacharyya S, Ghosh H, Hamza A, Biersack B, Gan GN, Sharma P, Dandawate P.
PMID: 42488503 [PubMed]
Additional chemoradiotherapy versus esophagectomy for early esophageal cancer: an integrated analysis of reconstructed time-to-event data.
Ther Adv Gastroenterol
Huang PF, Chen YG, Lu MC, Yang CW.
PMID: 42488030 [PubMed]
Prognostic Factors in Upper Gastrointestinal Neuroendocrine Carcinoma: A Retrospective Cohort Study of Clinicopathological Features and Survival Outcomes.
Cancer Manag Res
, Gökmen A.
PMID: 42483270 [PubMed]
Extent of Lymphadenectomy in Esophageal Cancer Surgery: Unresolved Issues in Prophylactic 3-Field Dissection.
J Chest Surg
Tsunoda S, Sakaguchi M, Okumura S, Kitano S, Obama K.
PMID: 42482330 [PubMed - as supplied by publisher]
Articles 1 - 20 / 39361
Page 1 de 1969
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité